DIUXF (Diaceutics) Momentum Rank: 7 (As of Aug. 14, 2026) — 13% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DIUXF Diaceutics PLC DIUXF
87 GF Score
Price $2.00
GF Value $2.55
! 1 Warning Sign
View Full Analysis

What is Diaceutics Momentum Rank?

Diaceutics DIUXF 87 Momentum Rank is 7 as of Aug. 14, 2026, which is 13% below its 10-year median of 8.00. GuruFocus rates DIUXF with a GF Score™ of 87/100 and a GF Value™ of $2.55. The stock has 1 warning sign investors should review.

Diaceutics has the Momentum Rank of 7.

Momentum Rank measures the strength and persistence of a stock's price movement over time, rated on a scale of 1 to 10.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

A higher score reflects strong price momentum and indicates greater potential for superior performance. Conversely, a lower score indicates that momentum is either too high or too low, and stocks tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

DIUXF vs VEEV, BTSG, HQY: Momentum Rank Comparison

For the Health Information Services subindustry, Diaceutics's Momentum Rank, along with its competitors' market caps and Momentum Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Diaceutics Momentum Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Diaceutics's Momentum Rank distribution charts can be found below:

* The bar in red indicates where Diaceutics's Momentum Rank falls into.


DIUXF
87GF Score
Diaceutics PLC DIUXF
Momentum Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Momentum Rank →
What does a Momentum Rank of 7 mean?
Diaceutics (DIUXF) has a Momentum Rank of 7 as of Aug. 14, 2026. Momentum Rank is determined using the standardized momentum ratio, measuring the speed and velocity of price changes in a stock. View historical data on Diaceutics and its competitors. This is 13% below median its historical median of 8.00. Over the past decade, Diaceutics' Momentum Rank has ranged from 1.00 to 10.00.
Is Diaceutics' Momentum Rank too high?
Diaceutics' current Momentum Rank of 7 is 13% below median its 10-year median of 8.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, Diaceutics has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does Diaceutics' Momentum Rank compare to VEEV and BTSG?
Diaceutics' Momentum Rank of 7 can be compared against companies in the Healthcare Providers & Services industry. Historically, Diaceutics' own Momentum Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Momentum Rank for a Healthcare Providers & Services company?
A good Momentum Rank depends on the Healthcare Providers & Services industry context. However, Momentum Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Momentum Rank mean?
A high Momentum Rank can signal that a stock is expensive relative to its fundamentals. Momentum Rank is determined using the standardized momentum ratio, measuring the speed and velocity of price changes in a stock. View historical data on Diaceutics and its competitors. Diaceutics's current Momentum Rank is 7, which is 13% below median its own 10-year median of 8.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diaceutics stock overvalued right now?
Diaceutics (DIUXF) has a current Momentum Rank of 7. The stock's GF Value™ is $2.55, compared to a current price of $2.00 — trading 21.6% below its estimated fair value. The current Momentum Rank is 7, which is 13% below median its 10-year median of 8.00. Diaceutics' overall GF Score™ is 87/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Momentum Rank calculated?
Momentum Rank is calculated from a company's financial statements. For Diaceutics (DIUXF), the current Momentum Rank is 7 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diaceutics (DIUXF) Overvalued in 2026?

Based on GuruFocus' analysis, Diaceutics stock appears to be undervalued. The current stock price of $2.00 is trading 21.6% below its estimated GF Value™ of $2.55.

Key valuation signals for DIUXF:

  • Momentum Rank: 7 (13% below median its 10-year median of 8.00)
  • GF Value™: $2.55 vs. price of $2.00 (21.6% below fair value)
  • GF Score™: 87/100 with 1 warning sign

No single metric tells the full story. See the DIUXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diaceutics Business Description

Other Exchanges DXRX:UK7DC:Germany
Address Dataworks at Kings Hall Health & Wellbeing Park, First Floor, Building Two, County Antrim, Belfast, GBR, BT9 6GW
Diaceutics PLC is a data analytics and implementation services company that services the pharmaceutical industry. It provides integrated commercialization solutions that help biopharma companies maximize patient access, accelerate uptake, and improve the lifetime value of their therapies. The group's services span the full commercial lifecycle, from pre-launch ideas through to mature brand optimization, delivered through an integrated combination of data, technology, and expertise. Its DXRX Data Solutions include DXRX Signal, DXRX Physician Segmentation, DXRX Lab Segmentation, and DXRX Disease Testing Rate Tracker. Geographical market by customer location in the UK, North America, Europe, Asia, and the rest of the world.
87GF Score

Get the complete analysis for DIUXF

Momentum Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.00
Price
$2.55
GF Value